Figure 4
(A) Protein levels of Cyclin D-1/β-actin (a.u) in prostatic tissue; (B) Protein levels of P-16/β-actin (a.u) in prostatic tissue; (C) Protein levels of p-21/β-actin (a.u) in prostatic tissue; (D) Protein levels of p-27/β-actin (a.u) in prostatic tissue; (E) Protein levels of BCL-2/β-actin (a.u); (F) Protein levels of BAX/β-actin (a.u); (G) Ratio between BCL-2/BAX (a.u); (H) Protein levels of Caspase-3/β-actin (a.u); (I) Protein levels of p-53/β-actin (a.u); (J) NOS-2 mRNA levels (a.u) obtained by PCR-RT analysis in prostate; (K) SOD-1 mRNA levels (a.u) obtained by PCR-RT analysis in frozen prostate; (L) GSS mRNA levels (a.u) obtained by PCR-RT analysis in frozen prostate; (M) CAT mRNA levels (a.u) obtained by PCR-RT analysis in prostate; au = arbitrary unit; (N) Representative protein levels of p-16 and p-21 proteins; BCL-2, BAX, Caspase-3, Cyclin D-1 proteins in Western Blotting; (O) Representative Western Blotting of p-27 and p-53 proteins.
